Martina B. Schafer
Bonn, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Structural analysis of the flexibility of the Ubl2 domain within the papain-like protease of SARS-CoV-2.
Journal: Acta crystallographica. Section F, Structural biology communications
Published: January 12, 2026
Feasibility of Integrating a Standardized Psychosocial Follow-Up After Childhood Cancer-An Interim Analysis of the LE-Na Study.
Journal: Cancer medicine
Published: October 31, 2025
Discovery and Preclinical Characterization of Fulacimstat (BAY 1142524), a Potent and Selective Chymase Inhibitor As a New Profibrinolytic Approach for Safe Thrombus Resolution.
Journal: Journal of medicinal chemistry
Published: November 14, 2024
Discovery of BAY 2413555, First Selective Positive Allosteric Modulator of the M2 Receptor to Restore Cardiac Autonomic Balance.
Journal: Journal of medicinal chemistry
Published: October 28, 2024
Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer.
Journal: Journal of medicinal chemistry
Published: September 27, 2024
Surface-mutagenesis strategies to enable structural biology crystallization platforms.
Journal: Acta crystallographica. Section D, Structural biology
Published: May 09, 2024
BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 Inhibitor.
Journal: Journal of medicinal chemistry
Published: February 13, 2024
Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839.
Journal: Journal of medicinal chemistry
Published: January 16, 2024
Healthy, Inclusive and Sustainable Catering in Secondary Schools-An Analysis of a Transformation Process with Multiple Tensions.
Journal: International journal of environmental research and public health
Published: December 17, 2023
Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders.
Journal: Journal of medicinal chemistry
Published: September 05, 2023
New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension.
Journal: Journal of medicinal chemistry
Published: April 11, 2023
Last Updated: 09/26/2026